China – Full of Potential for Infant Formula Producers
26pages

- We analyze the implications of a potential relaxatio
of China’s one-child policy for the Infant Milk
Formula (IMF) industry and the key competitors.
- Even if there is no change at all to the policy, the
Chinese IMF market should grow at least in the low
teens for the foreseeable future.
- We model two alternative scenarios: only partial
relaxation or a two-children policy.
- Danone and Mead Johnson likely to focus on
organic growth, Nestle could be tempted to acquire
market share.